IMR Press / FBL / Volume 18 / Issue 1 / DOI: 10.2741/4091

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.


Nutrition in oncologic patients during antiblastic treatment

Show Less
1 Department of Medical Oncology, National Cancer Institute Aviano (Pn), Italy
2 Laboratory of Molecular Hematology, National Cancer Institute, G. Pascale, Naples, Italy
3 Department of Surgery, University of Catania, Catania, Italy
4 Department of Biological Chemistry, Medical Chemistry, Molecular Biology, University of Catania, Catania, Italy
Academic Editor:Fabio Galvano
Front. Biosci. (Landmark Ed) 2013, 18(1), 120–132;
Published: 1 January 2013
(This article belongs to the Special Issue Dietary approaches to prevent chronic-degenerative diseases)

Cancer may induce weight loss and cachexia, and cancer treatment may contribute to nutritional impairment. Here, we review the literature on the mechanisms of cancer cachexia and the pharmacological interventions both in use in clinical practice and currently under development. Based on this analysis, several nutritional proposals for cancer patients are suggested and the importance of good nutritional status in candidates for hematopoietic stem cell transplantation is highlighted.

Antiblastic chemotherapy
Hematopoietic stem cell transplantation
Back to top